Magazine

The leading source for ASAM society and addiction medicine news.

ASAM Applauds FDA Recommendation to Reschedule Hydrocodone

by Magazine Staff | Nov 04, 2013

The American Society of Addiction Medicine (ASAM) applauds the FDA’s recommendation to reschedule hydrocodone combination products into a more tightly controlled class of narcotics. ASAM has advocated for the change since September 2011, when it sent a letter to the FDA Commissioner in response to an Associated Press news story that called the level of hydrocodone abuse a “national crisis.” 

ASAM recognizes the important role that opioid analgesics play in the management of chronic, severe pain. However, most opioid analgesic prescribers have had little to no formal pain management or addiction treatment training. According to Dr. Brad Hall,  a little education about pain management and addiction risk evaluation could go a long way toward stemming the opioid epidemic and overdose rates.

Read ASAM’s press release here.

Features

PCSS Graphic

Ask the PCSS Expert: Counseling Requirements in Addiction Treatment?

A physician wrote the PCSS mentor network seeking advice on what type of counseling (group/individual/ AA, NA/ therapist) are typically required as part of addiction treatment.

neurons

Brain Stimulation as a Potential Treatment for Addiction

Brain stimulation has been in use for decades as a potential treatment for psychiatric disorders. However, its use in addiction is relatively new.

Unite ImageJoin Rally and Advocate for Addiction Solutions

Help tell our nation’s leaders that we support public health solutions to addiction.

image of the ASAM sealASAM Speaks on FDA Boxed Warnings

ASAM testified on the best approaches to communicating information about the fetal effects in product labeling for methadone and buprenorphine

Photo of Alex Krawczyk-KeefeThe Importance of Donating: One Family’s Story

A donation to honor a son and help those facing the devastating disease of addiction.

Education & Training

ASAM Applauds FDA Recommendation to Reschedule Hydrocodone

by Magazine Staff | Nov 04, 2013

The American Society of Addiction Medicine (ASAM) applauds the FDA’s recommendation to reschedule hydrocodone combination products into a more tightly controlled class of narcotics. ASAM has advocated for the change since September 2011, when it sent a letter to the FDA Commissioner in response to an Associated Press news story that called the level of hydrocodone abuse a “national crisis.” 

ASAM recognizes the important role that opioid analgesics play in the management of chronic, severe pain. However, most opioid analgesic prescribers have had little to no formal pain management or addiction treatment training. According to Dr. Brad Hall,  a little education about pain management and addiction risk evaluation could go a long way toward stemming the opioid epidemic and overdose rates.

Read ASAM’s press release here.

Government Affairs

ASAM Applauds FDA Recommendation to Reschedule Hydrocodone

by Magazine Staff | Nov 04, 2013

The American Society of Addiction Medicine (ASAM) applauds the FDA’s recommendation to reschedule hydrocodone combination products into a more tightly controlled class of narcotics. ASAM has advocated for the change since September 2011, when it sent a letter to the FDA Commissioner in response to an Associated Press news story that called the level of hydrocodone abuse a “national crisis.” 

ASAM recognizes the important role that opioid analgesics play in the management of chronic, severe pain. However, most opioid analgesic prescribers have had little to no formal pain management or addiction treatment training. According to Dr. Brad Hall,  a little education about pain management and addiction risk evaluation could go a long way toward stemming the opioid epidemic and overdose rates.

Read ASAM’s press release here.

Your ASAM

ASAM Applauds FDA Recommendation to Reschedule Hydrocodone

by Magazine Staff | Nov 04, 2013

The American Society of Addiction Medicine (ASAM) applauds the FDA’s recommendation to reschedule hydrocodone combination products into a more tightly controlled class of narcotics. ASAM has advocated for the change since September 2011, when it sent a letter to the FDA Commissioner in response to an Associated Press news story that called the level of hydrocodone abuse a “national crisis.” 

ASAM recognizes the important role that opioid analgesics play in the management of chronic, severe pain. However, most opioid analgesic prescribers have had little to no formal pain management or addiction treatment training. According to Dr. Brad Hall,  a little education about pain management and addiction risk evaluation could go a long way toward stemming the opioid epidemic and overdose rates.

Read ASAM’s press release here.

OP-ED

ASAM Applauds FDA Recommendation to Reschedule Hydrocodone

by Magazine Staff | Nov 04, 2013

The American Society of Addiction Medicine (ASAM) applauds the FDA’s recommendation to reschedule hydrocodone combination products into a more tightly controlled class of narcotics. ASAM has advocated for the change since September 2011, when it sent a letter to the FDA Commissioner in response to an Associated Press news story that called the level of hydrocodone abuse a “national crisis.” 

ASAM recognizes the important role that opioid analgesics play in the management of chronic, severe pain. However, most opioid analgesic prescribers have had little to no formal pain management or addiction treatment training. According to Dr. Brad Hall,  a little education about pain management and addiction risk evaluation could go a long way toward stemming the opioid epidemic and overdose rates.

Read ASAM’s press release here.